MedPath

Geri-kot

gc 454

Approved
Approval ID

7aa66bf1-d765-adce-e053-2991aa0a93a3

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 15, 2025

Manufacturers
FDA

Geri-Care Pharmaceutical Corp

DUNS: 611196254

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Standardized Senna Concentrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code57896-454
Application Number505G(a)(3)
Product Classification
M
Marketing Category
C200263
G
Generic Name
Standardized Senna Concentrate
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2025
FDA Product Classification

INGREDIENTS (11)

MAGNESIUM SILICATEInactive
Code: 9B9691B2N9
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
SENNOSIDESActive
Quantity: 8.6 mg in 1 1
Code: 3FYP5M0IJX
Classification: ACTIB
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: L11K75P92J
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 8/1/2018

Package Label

1

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 3/6/2013

Uses

  • relieves occasional constipation (irregularity)

  • generally produces bowel movement in 6 to 12 hours

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 3/6/2013

Active ingredient (in each tablet)

Sennosides 8.6 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 3/6/2013

Purpose

Laxative

WARNINGS SECTION

LOINC: 34071-1Updated: 8/1/2018

Warnings

Do not use

for more than 1 week unless directed by a doctor.

Ask a doctor before use if you

  • have abdominal pain, nausea or vomiting
  • have noticed a sudden change in bowel habits that lasts over 2 weeks

Stop use and ask a doctor ifyou have rectal bleeding or fail to
have a bowel movement after use of a laxative.
These may indicate a serious condition**.**

If pregnant or breast-feeding,

ask a health professional before use.

**Keep out of reach of children.**In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 3/6/2013

Directions

• do not exceed 8 tablets in 24 hours

Age

Starting Dose

Maximum Dose

adults and children 12 years of age and older

2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor

4 tablets in the morning and 4 tablets at bedtime

children under 12 years

ask a doctor

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 8/1/2018

Other information

*each tablet contains: calcium 40 mg *Tamper Evident: Do not use if imprinted seal under cap is missing or broken

  • store at room temperature

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 8/1/2018

Inactive ingredients

cellulose, croscarmellose sodium,
dicalcium phosphate, hypromellose*, magnesium silicate*,
magnesium stearate, mineral oil*, PEG*, silica*, wax*.
*May contain these ingredients

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.